ReviewCardiovascular endocrinology & metabolism2025
Meta-analysis of outcomes in patients developing acute kidney injury after endovascular aortic repair for Stanford type B aortic dissection.
Review in Cardiovascular endocrinology & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thoracic endovascular aortic repair (TEVAR) is recommended for patients with Stanford type B aortic dissection at risk of aneurysm rupture or enlargement. Although studies suggest that postoperative acute kidney injury (AKI) may worsen outcomes and increase mortality, its specific impact in TEVAR-treated patients remains uncertain. To address this, a meta-analysis was conducted comparing outcomes in patients who developed AKI post-TEVAR versus those who did not. A comprehensive literature search identified three studies involving 1091 patients, with 234 in the AKI group and 857 in the non-AKI group. Relative risks (RRs) were pooled using random-effects models, with statistical significance set at
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.